Steroid biochemistry.

Accurate analysis of steroid hormones represents an essential part in the evaluation of a patient with disorders or differences in sex development. Analytical methods based on mass spectrometry (MS) have become the state-of-the-art methodology allowing for the most specific qualitative and quantitative determination of steroid hormones and their metabolites. Liquid chromatography linked with tandem MS (LC-MS/MS) allows for rapid as well as highly specific and sensitive targeted steroid hormone analysis of multiple analytes from a single sample. Urinary steroid profile analysis by gas chromatography (GC)-MS is a non-invasive diagnostic approach and provides qualitative and quantitative data on the global excretion of steroid hormone metabolites. GC-MS remains the most powerful discovery tool for defining inborn errors of steroidogenesis, whereas LC-MS/MS represents a highly sensitive and specific method for targeted steroid hormone analysis.

[1]  O. Hiort,et al.  Understanding Differences and Disorders of Sex Development (DSD) , 2014 .

[2]  N. Krone,et al.  A diagnosis not to be missed: nonclassic steroid 11β-hydroxylase deficiency presenting with premature adrenarche and hirsutism. , 2013, The Journal of clinical endocrinology and metabolism.

[3]  B. Keevil,et al.  The use of mass spectrometry to improve the diagnosis and the management of the HPA axis , 2013, Reviews in Endocrine and Metabolic Disorders.

[4]  M. Hartmann,et al.  Introduction to gas chromatography-mass spectrometry. , 2013, Methods in molecular biology.

[5]  U. Steuerwald,et al.  Neonatal Screening: Identification of Children with 11β-Hydroxylase Deficiency by Second-Tier Testing , 2012, Hormone Research in Paediatrics.

[6]  T. Ogata,et al.  Two-step biochemical differential diagnosis of classic 21-hydroxylase deficiency and cytochrome P450 oxidoreductase deficiency in Japanese infants by GC-MS measurement of urinary pregnanetriolone/ tetrahydroxycortisone ratio and 11β-hydroxyandrosterone. , 2012, Clinical chemistry.

[7]  Z. Hochberg,et al.  Increased activation of the alternative "backdoor" pathway in patients with 21-hydroxylase deficiency: evidence from urinary steroid hormone analysis. , 2012, The Journal of clinical endocrinology and metabolism.

[8]  C. Shackleton,et al.  A Missense Mutation in the Human Cytochrome b5 Gene causes 46,XY Disorder of Sex Development due to True Isolated 17,20 Lyase Deficiency , 2011, The Journal of clinical endocrinology and metabolism.

[9]  M. Dattani,et al.  Genotype-Phenotype Analysis in Congenital Adrenal Hyperplasia due to P450 Oxidoreductase Deficiency , 2011, The Journal of clinical endocrinology and metabolism.

[10]  J. Honour,et al.  Recognition of 5α-reductase-2 deficiency in an adult female 46XY DSD clinic. , 2011, European journal of endocrinology.

[11]  M. Hartmann,et al.  Mass Spectrometry in the Diagnosis of Steroid-Related Disorders: Clinical Applications , 2011 .

[12]  W. Miller,et al.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. , 2011, Endocrine reviews.

[13]  G. Lavery,et al.  Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS) , 2010, The Journal of Steroid Biochemistry and Molecular Biology.

[14]  O. Soldin,et al.  Steroid hormone analysis by tandem mass spectrometry. , 2009, Clinical chemistry.

[15]  Z. Hochberg,et al.  Metabolic evidence for impaired 17alpha-hydroxylase activity in a kindred bearing the E305G mutation for isolate 17,20-lyase activity. , 2008, European journal of endocrinology.

[16]  C. Shackleton.  Genetic Disorders of Steroid Metabolism Diagnosed by Mass Spectrometry , 2008 .

[17]  U. Steuerwald,et al.  Newborn screening for congenital adrenal hyperplasia: additional steroid profile using liquid chromatography-tandem mass spectrometry. , 2007, The Journal of clinical endocrinology and metabolism.

[18]  N. Krone,et al.  Congenital adrenal hyperplasia and P450 oxidoreductase deficiency , 2007, Clinical endocrinology.

[19]  R. Auchus.  The backdoor pathway to dihydrotestosterone , 2004, Trends in Endocrinology & Metabolism.

[20]  C. Shackleton,et al.  Congenital adrenal hyperplasia caused by mutant P450 oxidoreductase and human androgen synthesis: analytical study , 2004, The Lancet.

[21]  P. Stewart,et al.  A Male Twin Infant with Skull Deformity and Elevated Neonatal 17–Hydroxyprogesterone: A Prismatic Case of P450 Oxidoreductase Deficiency , 2004, Endocrine research.

[22]  Kenneth L. Jones,et al.  The diagnosis of congenital adrenal hyperplasia in the newborn by gas chromatography/mass spectrometry analysis of random urine specimens. , 2002, The Journal of clinical endocrinology and metabolism.

[23]  M. Volmer,et al.  Detection of 3 beta-hydroxysteroid dehydrogenase deficiency in a newborn by means of urinary steroid analysis. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[24]  J. Imperato-McGinley,et al.  The Diagnosis of 5α-Reductase Deficiency in Infancy , 1986 .

[25]  R. E. Peterson,et al.  Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. , 1985, The New England journal of medicine.

[26]  A. Bongiovanni,et al.  Urinary steroidal pattern of infants with congenital adrenal hyperplasia due to 3-beta-hydroxysteroid dehydrogenase deficiency. , 1980, Journal of steroid biochemistry.